Next report date
Report period
Q2 2024
EPS estimate
—
Revenue estimate
—
4.89 MCNY
10.02 BCNY
772.03 M
Om NORTH CHINA PHARMACEUTICAL COMPANY. LTD
Sektor
Bransch
VD
Xin Yan Liu
Webbplats
Huvudkvarter
Shijiazhuang
Employees (FY)
10.16 K
Grundat
1992
ISIN
CNE000000D16
FIGI
BBG000BKC6P8
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
